Expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to sickle cell disease.

Bill: 114-hres-903
Sponsor: full_name: Rep. Davis, Danny K. [D-IL-7]
Introduced: 2016-09-28
Policy area: Health
Subjects: Blood and blood diseases

Commemorative events and holidays

Health promotion and preventive care

Hereditary and development disorders

Minority health
Latest action: action_date: 2016-09-28
text: Referred to the House Committee on Oversight and Government Reform.

Summaries:
action_date: 2016-09-28
action_desc: Introduced in House
text: <p> Expresses support for the goals and ideals of Sickle Cell Disease Awareness Month. (Sickle cell disease is an inherited blood disorder than can lead to pain, anemia, infections, and stroke.)</p> <p>Encourages people to hold events and activities to raise awareness of preventive care programs, treatments, and other patient services for those suffering from sickle cell disease.</p>

tv_txt: IV 114th CONGRESS 2d Session H. RES. 903 IN THE HOUSE OF REPRESENTATIVES September 28, 2016 Mr. Danny K. Davis of Illinois (for himself and Mr. Rangel ) submitted the following resolution; which was referred to the Committee on Oversight and Government Reform RESOLUTION Expressing support for the designation of the month of September 2016 as Sickle Cell Disease Awareness Month in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to sickle cell disease.

Whereas sickle cell disease (in this preamble referred to as SCD ) is an inherited blood disorder that is a major health problem in the United States and worldwide; Whereas SCD causes the rapid destruction of sickle cells, which results in multiple medical complications, including anemia, jaundice, gallstones, strokes, restricted blood flow, damaged tissue in the liver, spleen, and kidneys, and death; Whereas SCD causes episodes of considerable pain in the arms, legs, chest, and abdomen of an individual; Whereas SCD affects an estimated 100,000 individuals in the United States; Whereas approximately 1,000 babies are born with SCD each year in the United States, with the disease occurring in approximately 1 in 365 newborn African-American infants and 1 in 16,300 newborn Hispanic-American infants and is found in individuals of Mediterranean, Middle Eastern, Asian, and Indian origin; Whereas more than 3,000,000 individuals in the United States have the sickle cell trait and 1 in 13 African-Americans carries the trait; Whereas there is a 1 in 4 chance that a child born to parents who both have the sickle cell trait will have the disease; Whereas the life expectancy of an individual with SCD is often severely limited; Whereas, while hematopoietic stem cell transplantation (commonly known as HSCT ) is currently the only cure for SCD and advances in treating the associated complications of SCD have occurred, more research is needed to find widely available treatments and cures to help patients with SCD; and Whereas September 2016 has been designated as Sickle Cell Disease Awareness Month in order to educate communities across the United States about SCD, including early detection methods, effective treatments, and preventative care programs with respect to SCD: Now, therefore, be it

That the House of Representatives— (1) supports the goals and ideals of Sickle Cell Disease Awareness Month; and (2) encourages the people of the United States to hold appropriate programs, events, and activities during Sickle Cell Disease Awareness Month to raise public awareness of preventative care programs, treatments, and other patient services for those suffering from sickle cell disease.